TNFα concentrations and mRNA expression are increased in preeclamptic placentas

Journal of Reproductive Immunology

Volumn 32, Issue 2, 1996, Pages 157-169

  Wang, Yuping ^a   Walsh, Scott W ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Lipid peroxides; mRNA expression; Placenta; Preeclampsia; TNF

Indexed keywords

CYTOKINE; LIPID PEROXIDE; MESSENGER RNA; OXYGEN RADICAL; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL DIFFERENTIATION; CELL GROWTH; CLINICAL ARTICLE; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOREGULATION; LIPID PEROXIDATION; OXIDATIVE STRESS; PLACENTA VILLUS; PREECLAMPSIA; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPECTROPHOTOMETRY; TISSUE CULTURE;

ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LIPID PEROXIDES; PLACENTA; PRE-ECLAMPSIA; PREGNANCY; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030465347     PISSN: 01650378     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0378(96)00998-9     Document Type: Article

References (35)

1. Austgulen, R., Espevik, T., Mecsei, R. and Scott, H. (1992) Expression of receptors for tumor necrosis factor in human placenta at term. Acta Obstet. Gynecol. Scand. 71, 417-424.
2. Bulmer, J.N. and Johnson, P.M. (1984) Macrophage populations in the human placenta and amniochorion. Clin. Exp. Immunol. 57, 393-403.
3. Butterworth, B.H., Greer, I.A., Liston, W.A., Haddad, N.G. and Johnston, T.A. (1991) Immunocytochemical localization of neutrophil elastase in term placenta decidua and myometrium in pregnancy-induced hypertension. Br. J. Obstet. Gynaecol. 98, 929-933.
4. Chen, H-L., Yang, Y., Hu, X-L., Yelavarthi, K.K., Fishback, J.L. and Hunt, J.S. (1991) Tumor necrosis factor alpha mRNA and protein are present in human placental and uterine cells at early and late stages of gestation. Am. J. Pathol. 139, 327-335.
5. Chomczynski, P. and Sacchi, N. (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162, 156-159.
6. Endo, H., Akahoshi, T. and Kashiwazaki, S. (1988) Additive effects of IL-1 and TNF on induction of prostacyclin synthesis in human vascular endothelial cells. Biochem. Biophys. Res. Commun. 156, 1007-1014.
7. Feng, L., Xia, Y., Garcia, G.E., Hwang, D. and Wilson, C.B. (1995) Involvement of reactive oxygen intermediates in cyclooxygenase-2 expression induced by interleukin-1, tumor necrosis factor-α, and lipopolysaccharide. J. Clin. Invest. 95, 1669-1675.
8. Frew, J.E., Jones, P. and Scholes, G. (1983) Spectrophotometric determination of hydrogen peroxide and organic hydroperoxides at low concentrations in aqueous solution. Anal Chim. Acta. 155, 139-150.
9. Gamble, J.R., Harlan, J.M., Klebanoff, S.J. and Vadas, M.A. (1985) Stimulation of the adherence of neutrophils to umbilical vein endothelium by human recombinant tumor necrosis factor. Proc. Natl. Acad. Sci. U.S.A. 82, 8667-8671.
10. Greer, I.A., Haddad, N.G., Dawes, J., Johnstone, F.D. and Calder, A.A. (1989) Neutrophil activation in pregnancy-induced hypertension. Br. J. Obstet. Gynaecol. 96, 978-982.
11. Haeger, M., Unander, M., Norder-Hansson, B., Tylman, M. and Bengtsson, A. (1992) Complement, neutrophil, and macrophage activation in women with severe preeclampsia and the syndrome of hemolysis, elevated liver enzymes, and low platelet count. Obstet. Gynecol. 79, 19-26.
12. Hunt, J.S. (1989a) Macrophages in human uteroplacental tissues: a review. Am. J. Reprod. Immunol. 21, 119-122.
13. Hunt, J.S. (1989b) Cytokine networks in the uteroplacental unit: macrophages as pivotal regulatory cells. J. Reprod. Immunol. 16, 1-17.
14. Hunt, J.S., Chen, H-L. and Miller, L. (1996) Tumor necrosis factors: pivotal components of pregnancy? Biol. Reprod. 54, 554-562.
15. Jaattela, M., Kuusela, P. and Saksela, E. (1988) Demonstration of tumor necrosis factor in human amniotic fluids and supernatants of placental and decidual tissues. Lab. Invest. 58, 48-52.
16. Jensen, J.C., Pogrebniak, H.W., Pass, H.I., Buresh, C., Merino, M.J., Kauffman, D., Venzon, D., Langstein, H.N. and Norton, J.A. (1992) Role of tumor necrosis factor in oxygen toxicity. J. Appl. Physiol. 72, 1902-1907.
17. Kauma, S., Matt, D., Strom, S., Eierman, D. and Turner, T. (1990) Interleukin-1β, human leukocyte antigen HLA-DRα, and transforming growth factor-β expression in endometrium, placenta, and placental membranes. Am. J. Obstet. Gynecol. 163, 1430-1437.
18. Kauma, S.W., Aukerman, S.L., Eierman, D. and Turner, T.T. (1991) Colony-stimulating factor-1 and c-fms expression in human endometrial tissues and placenta during the menstrual cycle and early pregnancy. J. Clin. Endocrinol. Metab. 73, 746-751.
19. Kong, X-J. and Fanburg, B.L. (1992) Regulation of Cu, Zn-superoxide dismutase in bovine pulmonary artery endothelial cells. J. Cell. Physiol. 153, 491-497.
20. Kukreja, R.C., Kontos, H.A., Hess, M.L. and Ellis, E.F. (1986) PGH synthase and lipoxygenase generate superoxide in the presence of NADH or NADPH, Circ. Res. 59, 612-619.
21. Kupfermine, M.J., Peaceman, A.M., Wigton, T.R., Rehnberg, K.A. and Socol, M.L. (1994) Tumor necrosis factor-α is elevated in plasma and amniotic fluid of patients with severe preeclampsia. Am. J. Obstet. Gynecol. 170, 1752-1759.
22. Matthews, N., Neale, M.L., Jackson, S.K. and Stark, J.M. (1987) Tumour cell killing by tumour necrosis factor: inhibition by anaerobic conditions, free-radical scavengers and inhibitors of arachidonate metabolism. Immunol. 62, 153-155.
23. O'Brien-Ladner, A.R., Nelson, M.E., Cowley, B.D. Jr., Bailey, K. and Wesselius, L.J. (1995) Hyperoxia amplifies TNF-α production in LPS-stimulated human alveolar macrophages. Am. J. Respir. Cell. Mol. Biol. 12, 275-279.
24. Ohashi, K., Saji, F., Kato, M., Wakimoto, A. and Tanizawa, O. (1992) Tumor necrosis factor-α inhibits human chorionic gonadotropin secretion. J. Clin. Endocrinol. Metab. 74, 130-134.
25. Opsjon, S.-L., Novick, D., Wathen, N.C., Cope, A.P., Wallach, D. and Aderka, D. (1995) Soluble tumor necrosis factor receptors and soluble interleukin-6 receptor in fetal and maternal sera, coelomic and amniotic fluids in normal and pre-eclamptic pregnancies. J. Reprod. Immunol. 29, 119-134.
26. Radeke, H.H., Meier, B., Topley, N., Floge, J., Habermehl, G.G. and Resch, K. (1990) Interleukin 1-α and tumor necrosis factor-α induce oxygen radical production in mesangial cells. Kidney Int. 37, 767-775.
27. Tsukimori, K., Maeda, H., Ishida, K., Nagata, H., Koyanagi, T. and Nakano, H. (1993) The superoxide generation of neutrophils in normal and preeclamptic pregnancies. Obstet. Gynecol. 81, 536-540.
28. Vince, G.S., Starkey, P.M., Austgulen, R., Kwiatkowski, D. and Redman, C.W.G. (1995) Interleukin-6, tumour necrosis factor and soluble tumour necrosis factor receptors in women with pre-eclampsia. Br. J. Obstet. Gynaecol. 102, 20-25.
29. Walsh, S.W. (1985) Preeclampsia: An imbalance in placental prostacyclin and thromboxane production. Am. J. Obstet. Gynecol. 152, 335-340.
30. Walsh, S.W. and Wang, Y. (1995) Trophoblast and placental villous core production of lipid peroxides, thromboxane, and prostacyclin in preeclampsia. J. Clin. Endocrinol. Metab. 80, 1888-1893.
31. Wang, Y., Walsh, S.W. and Kay, H.H. (1992) Placental lipid peroxides and thromboxane are increased and prostacyclin is decreased in women with preeclampsia. Am. J. Obstet. Gynecol. 167, 946-949.
32. Wong, G.H.W. and Goeddel, D.V. (1988) Induction of manganous superoxide dismutase by tumor necrosis factor: possible protective mechanism. Science 242, 941-944.
33. Wong, G.H.W., Elwell, J.H., Oberley, L.W. and Goeddel, D.V. (1989) Manganous superoxide dismutase is essential for cellular resistance to cytotoxicity of tumor necrosis factor. Cell 58, 923-931.
34. Yamauchi, N., Kuriyama, H., Watanabe, N., Neda, H., Maeda, M. and Niitsu, Y. (1989) Intracellular hydroxyl radical production induced by recombinant human tumor necrosis factor and its implication in the killing of tumor cells in vitro. Cancer Res. 49, 1671-1675.
35. Zimmerman, R.J., Chan, A. and Leadon, S.A. (1989) Oxidative damage in murine tumor cells treated in vitro by recombinant human tumor necrosis factor. Cancer Res. 49, 1644-1648.